Shots: Roche divulges new data that demonstrate Ocrevus (ocrelizumab) is a highly effective treatment option for people with RRMS who experienced a suboptimal response to their prior DMT. In open-label […]readmore
Tags : MSVirtual2020
Biotech
Clinical Trials
Genentech to Present New Data of Enspryng (satralizumab-mwge) for Neuromyelitis
Shots: Genentech reports the new data for Enspryng on reducing relapse severity in the treatment of neuromyelitis optical spectrum disorder (NMOSD), to be presented at MSVirtual2020. In a pos-thoc analysis, […]readmore
Shots: Sanofi Genzyme reports the new data from the company’s neurology portfolio, to be presented at MSVirtual2020. The company will highlight new data on tolebrutinib (SAR442168), supporting its potential in […]readmore